NCT06326970View on ClinicalTrials.gov

SPECT Fibroblast Activation Protein Imaging in Patients With Cardiac Disease

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Myocardial Fibrosis
Interventions
DIAGNOSTIC_TEST

99mTc-FAPI SPECT imaging

99mTc radionuclide is labeled to a HYINC-FAPI-04 probe as a tracer. SPECT imaging was performed 2 hours after 99mTc-FAPI intravenous injection into the subject, and image processing and quantitative analysis were performed using the Q.Volumetrix MI System software package.

All Listed Sponsors
lead

Henan Institute of Cardiovascular Epidemiology

OTHER

NCT06326970 - SPECT Fibroblast Activation Protein Imaging in Patients With Cardiac Disease | Biotech Hunter | Biotech Hunter